Dutch court found Merck infringing Halozyme's MDASE patent EP622, granted injunction in eight European countries, rejected invalidity arguments. IV Keytruda unaffected. Halozyme previously won German injunction and has US suit.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
